Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis

NCT05622526 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Patients With Nonalcoholic Steatohepatitis

Interventions

DRUG: Group 1 or Experimental group
OTHER: Group 2 or Control group

Sponsor

Instituto de Investigación Marqués de Valdecilla